×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Markets
Markets
FII & DII Activity
Corporate Action
Investment Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Monsoon Tracker
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Swing Trading Masterclass
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Specials
Pharma Industry Conclave
Unlocking opportunities in Metal and Mining
Mutual Fund Summit 2025
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
Personal Finance
Forum
Videos
you are here:
Home
News
Zetia
Zetia
Ads
Positive phase 3 data on GSP 301; USD 100m opportunity for co: Glenmark
Glenmark Q3 net soars 143% to Rs 477 cr aided by US generic biz
Q3 results: Five trends to watch out from Indian drugmakers
New launches to drive earnings growth in FY18 & FY19: Glenmark
See EBITDA margins at 25% over 10 years: Glenmark CMD
Glenmark launches generic version of Zetia in US
Glenmark to launch cholesterol drug Zetia in US on Dec 12
Zetia generic launch could help Glenmark trim debt: Surajit Pal
Use intermittent dips to buy; like Yes Bank: Prabhudas Lilladher
New products, regulatory approvals to drive growth for Glenmark
Analysts say Glenmark's FCCB, Zetia, licensing deal key in FY17
Glenmark Pharma up 3% on US FDA nod for cholesterol drug
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio